150 related articles for article (PubMed ID: 16568082)
21. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
22. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha.
Stannard AK; Khurana R; Evans IM; Sofra V; Holmes DI; Zachary I
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):494-502. PubMed ID: 17170373
[TBL] [Abstract][Full Text] [Related]
24. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
[TBL] [Abstract][Full Text] [Related]
25. Expression of carcinoembryonic antigen-related cell adhesion molecule 1 in acute rejection of human renal allografts.
Sager HB; Ergun S; Hartmann A; Hoffmann U; Krämer BK; Mihatsch MJ; Weil J
Transplant Proc; 2009 Jun; 41(5):1536-40. PubMed ID: 19545674
[TBL] [Abstract][Full Text] [Related]
26. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
28. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
Uzzo RG; Crispen PL; Golovine K; Makhov P; Horwitz EM; Kolenko VM
Carcinogenesis; 2006 Oct; 27(10):1980-90. PubMed ID: 16606632
[TBL] [Abstract][Full Text] [Related]
29. CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation.
Poliani PL; Mitola S; Ravanini M; Ferrari-Toninelli G; D'Ippolito C; Notarangelo LD; Bercich L; Wagener C; Memo M; Presta M; Facchetti F
J Pathol; 2007 Apr; 211(5):541-549. PubMed ID: 17310502
[TBL] [Abstract][Full Text] [Related]
30. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of carcinoembryonic antigen-related cell adhesion molecule 1 in oral squamous cell carcinoma: correlation with tumor progression and poor prognosis.
Shinozuka K; Uzawa K; Fushimi K; Yamano Y; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
Oncology; 2009; 76(6):387-97. PubMed ID: 19407471
[TBL] [Abstract][Full Text] [Related]
32. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
33. Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors.
Soleti R; Benameur T; Porro C; Panaro MA; Andriantsitohaina R; Martínez MC
Carcinogenesis; 2009 Apr; 30(4):580-8. PubMed ID: 19168578
[TBL] [Abstract][Full Text] [Related]
34. [CEACAM1--a less well-known member of the family of carcinoembryonic antigens].
Muchová L; Vítek L; Jirsa M
Cas Lek Cesk; 2003; 142(5):259-63. PubMed ID: 12920788
[TBL] [Abstract][Full Text] [Related]
35. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor.
Ergün S; Kilik N; Ziegeler G; Hansen A; Nollau P; Götze J; Wurmbach JH; Horst A; Weil J; Fernando M; Wagener C
Mol Cell; 2000 Feb; 5(2):311-20. PubMed ID: 10882072
[TBL] [Abstract][Full Text] [Related]
36. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
[TBL] [Abstract][Full Text] [Related]
37. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
38. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
Das S; Roth CP; Wasson LM; Vishwanatha JK
Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
[TBL] [Abstract][Full Text] [Related]
39. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
40. Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study.
Yao JL; Ryan CK; Francis CW; Kohli M; Taubman MB; Khorana AA
Cancer Invest; 2009 May; 27(4):430-4. PubMed ID: 19219655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
